Understanding and Targeting Tiam1 in Cancer
了解 Tiam1 并针对癌症进行靶向治疗
基本信息
- 批准号:10093529
- 负责人:
- 金额:$ 22.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-01-01 至 2022-12-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAmino Acid SequenceAnimal ModelAnimalsApplications GrantsAutomobile DrivingB-Cell LymphomasBiologicalBiological ProcessCell Cycle ProgressionCell ProliferationCellsColonColon CarcinomaColorectal CancerConsensus SequenceConserved SequenceCritical PathwaysCytoskeletonDataDevelopmentDiagnosisDiffuseDiseaseEventFamilyFutureGene ExpressionGenesGuanine Nucleotide Exchange FactorsGuanosine Triphosphate PhosphohydrolasesHomologous GeneHumanIn VitroInterventionMalignant - descriptorMalignant NeoplasmsMeasuresMediatingMetabolismModificationMolecularMonomeric GTP-Binding ProteinsMutateMutationNeoplasm MetastasisNormal CellNucleotidesOncogenicOutcomePathway interactionsPharmaceutical ChemistryPhosphorylationPhosphorylation SitePhysiologicalPost-Translational Protein ProcessingProtein BiosynthesisProto-OncogenesReagentResearchRoleSignal PathwaySignal TransductionSignal Transduction PathwaySite-Directed MutagenesisSpecificityStructureStructure-Activity RelationshipSurfaceTestingTissuesTyrosineTyrosine PhosphorylationWorkXenograft procedurebasecancer cellcancer therapycell motilitycell transformationcolon cancer treatmentcolon tumorigenesisefficacious interventionexperimental studyfunctional outcomesgain of function mutationimprovedin silicoin vivoinnovationmigrationmouse modelnew therapeutic targetnovelpromoterprotein functionprotein metabolismrhorho GTP-Binding Proteinssmall molecule inhibitortooltumortumorigenesis
项目摘要
Project Summary:
Understanding the detailed mechanisms that underlie proliferative signal transduction pathways is of critical
importance for developing strategies for diagnosis and treatment of human cancer. Because most proliferative
pathways are critical for the functioning of all normal cells, the development of cancer-cell-selective interventions
without off-target effects is tremendously important yet highly challenging. The research proposed in this grant
application focuses on unique ‘players’ in proliferative signaling, the guanine nucleotide exchange factors (GEFs)
from the Dbl (diffuse B cell lymphoma) family.
GEFs control proliferative signaling by stimulating nucleotide exchange on the small GTPases, Rho, Rac, and
Cdc42. In doing so, GEFs regulate numerous cellular activities such as gene expression, cytoskeletal
rearrangements, protein synthesis, and metabolism. Gain-of-function mutations in GEFs are associated with
multiple human cancers, and GEFs from the Dbl family constitute one of the largest families of proto-oncogenes.
Although different Dbl-family GEFs share similar mechanisms of action, their expression is extremely tissue- and
cell-specific, and their respective mutated forms are associated with distinct and different cancers. Thus,
intervention with GEF signaling may be extremely useful in multiple, seemingly unrelated malignant diseases.
The proposed work relies on our recent discovery of a novel tyrosine phosphorylation sequence motif
(TEXXYVXXL) that regulates the activity of some Dbl-like GEFs implicated in human cancers. We hypothesize
that selective interreference with this phosphorylation comprises a unique, novel and effective selective
intervention approach in relevant cancers. This proof-of-principle proposal focuses on Tiam1, a GEF whose
dysregulation drives colorectal tumorigenesis and metastasis. We propose to decipher the molecular
mechanisms and functional outcomes of TEXXYVXXL phosphorylation in Tiam1, and to test novel reagents that
target Tiam1’s tyrosine phosphorylation as selective intervention tools. In Specific Aim 1 we will decipher the role
of TEXXYVXXL phosphorylation in regulating Tiam1’s key activities, i.e. GTPase activation, cell invasion and
proliferation in vitro, and tumorigenesis and metastasis in vivo. In Specific Aim 2, we will evaluate the utility of
novel reagents that target Tiam1’s TEXXYVXXL phosphorylation site for intervention in a mouse model of colon
cancer. These proof-of-concept experiments in cells and animals will open the door for future development and
translational work in GEF-associated malignancies.
项目摘要:
了解细胞增殖信号转导途径的详细机制是至关重要的
对于开发用于诊断和治疗人类癌症的策略的重要性。因为大多数增殖性的
通路对于所有正常细胞的功能至关重要,癌细胞选择性干预的发展
没有脱靶效应是非常重要的,但也极具挑战性。这项研究计划
应用程序集中在增殖信号传导中的独特'球员',鸟嘌呤核苷酸交换因子(GEFs)
来自Dbl(弥漫性B细胞淋巴瘤)家族。
GEF通过刺激小GTP酶Rho、Rac和Rac上的核苷酸交换来控制增殖信号传导。
Cdc42。在此过程中,GEF调节许多细胞活动,如基因表达、细胞骨架、细胞周期和细胞周期。
重组、蛋白质合成和代谢。GEF中的功能获得性突变与
多种人类癌症,并且来自Db1家族的GEF构成原癌基因的最大家族之一。
尽管不同的Dbl家族GEF具有相似的作用机制,但它们的表达是极其组织和组织特异性的。
细胞特异性和它们各自的突变形式与不同的癌症相关。因此,在本发明中,
GEF信号的干预可能在多种看似无关的恶性疾病中非常有用。
这项工作的提出依赖于我们最近发现的一个新的酪氨酸磷酸化序列基序
(TEXXYVXXL),其调节涉及人类癌症的一些Dbl样GEF的活性。我们假设
与这种磷酸化的选择性相互参照包括独特的、新颖的和有效的选择性相互参照,
相关癌症的干预方法。该原理证明提案的重点是Tiam 1,这是一个GEF,
失调驱动结肠直肠肿瘤发生和转移。我们打算破译
Tiam 1中TEXXYVXXL磷酸化的机制和功能结果,并测试
靶向Tiam1的酪氨酸磷酸化作为选择性干预工具。在具体目标1中,我们将破译
TEXXYVXXL磷酸化在调节Tiam 1的关键活动,即GT3活化,细胞侵袭和
体外增殖和体内肿瘤发生和转移。在具体目标2中,我们将评估
靶向Tiam 1的TEXXYVXXL磷酸化位点的新型试剂用于干预小鼠结肠模型
癌这些在细胞和动物中的概念验证实验将为未来的发展打开大门,
GEF相关恶性肿瘤的转化工作。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DANNY MANOR其他文献
DANNY MANOR的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DANNY MANOR', 18)}}的其他基金
Understanding and Targeting Tiam1 in Cancer
了解 Tiam1 并针对癌症进行靶向治疗
- 批准号:
10322680 - 财政年份:2021
- 资助金额:
$ 22.58万 - 项目类别:
Functions of vitamin E and the tocopherol transfer protein
维生素 E 和生育酚转移蛋白的功能
- 批准号:
10541855 - 财政年份:2021
- 资助金额:
$ 22.58万 - 项目类别:
Functions of vitamin E and the tocopherol transfer protein
维生素 E 和生育酚转移蛋白的功能
- 批准号:
10394948 - 财政年份:2021
- 资助金额:
$ 22.58万 - 项目类别:
相似海外基金
Cerebral infarction treatment strategy using collagen-like "triple helix peptide" containing functional amino acid sequence
含功能氨基酸序列的类胶原“三螺旋肽”治疗脑梗塞策略
- 批准号:
23K06972 - 财政年份:2023
- 资助金额:
$ 22.58万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Establishment of a screening method for functional microproteins independent of amino acid sequence conservation
不依赖氨基酸序列保守性的功能性微生物蛋白筛选方法的建立
- 批准号:
23KJ0939 - 财政年份:2023
- 资助金额:
$ 22.58万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Effects of amino acid sequence and lipids on the structure and self-association of transmembrane helices
氨基酸序列和脂质对跨膜螺旋结构和自缔合的影响
- 批准号:
19K07013 - 财政年份:2019
- 资助金额:
$ 22.58万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Construction of electron-transfer amino acid sequence probe with an interaction for protein and cell
蛋白质与细胞相互作用的电子转移氨基酸序列探针的构建
- 批准号:
16K05820 - 财政年份:2016
- 资助金额:
$ 22.58万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of artificial antibody of anti-bitter taste receptor using random amino acid sequence library
利用随机氨基酸序列库开发抗苦味受体人工抗体
- 批准号:
16K08426 - 财政年份:2016
- 资助金额:
$ 22.58万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The aa15-17 amino acid sequence in the terminal protein domain of HBV polymerase as a viral factor affect-ing in vivo as well as in vitro replication activity of the virus.
HBV聚合酶末端蛋白结构域中的aa15-17氨基酸序列作为影响病毒体内和体外复制活性的病毒因子。
- 批准号:
25461010 - 财政年份:2013
- 资助金额:
$ 22.58万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Amino acid sequence analysis of fossil proteins using mass spectrometry
使用质谱法分析化石蛋白质的氨基酸序列
- 批准号:
23654177 - 财政年份:2011
- 资助金额:
$ 22.58万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Precise hybrid synthesis of glycoprotein through amino acid sequence-specific introduction of oligosaccharide followed by enzymatic transglycosylation reaction
通过氨基酸序列特异性引入寡糖,然后进行酶促糖基转移反应,精确杂合合成糖蛋白
- 批准号:
22550105 - 财政年份:2010
- 资助金额:
$ 22.58万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Estimating selection on amino-acid sequence polymorphisms in Drosophila
果蝇氨基酸序列多态性选择的估计
- 批准号:
NE/D00232X/1 - 财政年份:2006
- 资助金额:
$ 22.58万 - 项目类别:
Research Grant
Construction of a neural network for detecting novel domains from amino acid sequence information only
构建仅从氨基酸序列信息检测新结构域的神经网络
- 批准号:
16500189 - 财政年份:2004
- 资助金额:
$ 22.58万 - 项目类别:
Grant-in-Aid for Scientific Research (C)